Bio
Dr. Chang runs a full time glaucoma and cataract surgical practice with special expertise in minimally invasive glaucoma surgery (Hydrus, OMNI, ECP, KDB, Xen, MP3, Cypass, trabectome, ABiC/GATT, canaloplasty) and complex cataract removal with ORA, Callisto, and premium lenses (torics, trifocals, EDOF). He is an expert on optical coherence tomography (OCT) and helped develop the normative data of Zeiss Cirrus and Stratus machines. Besides providing state of the art clinical care, delving into cutting edge research, and delivering world class education locally and internationally, he is involved in the commercialization of novel mobile health devices and digital health startups as well as scientific advisor to multiple pharmaceutical and medical device companies. Current research interests include: high myopia and glaucoma, glaucoma biobanking, virtual reality visual fields and home IOP checks, glaucoma therapy compliance, telemedicine, computer vision machine learning algorithms, data warehouses, and decentralized big data sharing with differential privacy. He has championed QI/QA projects in technician wellness and completed Stanford leadership development training (LDP) and clinical effectiveness training (CELT).
Dr. Chang co-invented the EyeGo Smartphone imaging adapter, which was licensed and commercialized as the Paxos Scope. He co-founded a venture-backed seed stage consumer health startup. He is Vice President of the Asia Pacific Tele Ophthalmology Society and Medical Director of employer based optometry services. One of his original contributions is the creation of the digital health design sprint, a week-long, end-to-end project-based learning experience to help innovators be more aware of the challenges in starting a healthcare company. http://medcatalyst.stanford.edu
